Skip to content

Effect of Stimulant Medication on Loss of Control Eating in Youth With Attention Deficit/Hyperactivity Disorder

Attention Deficit/Hyperactivity Disorder | Loss of Control Eating

Loss of control eating (LOC-E) in youth predicts the later development of full syndrome eating disorders, such as binge-eating disorder (BED), and therefore, could be a relevant target for prevention interventions. Children with attention deficit/hyperactivity disorder (ADHD) are at higher risk of experiencing LOC-E than healthy controls, and there is evidence that related neurocognitive predisposing factors, such as impulsivity and dysfunctional reward processing, are associated with the pathogenesis of LOC-E. Therefore, it is pertinent to examine whether modifying these neurocognitive symptoms influences LOC-E and the subsequent development of eating disorders. Stimulants are an efficacious treatment for impulsivity in youth with ADHD and have been shown to improve symptoms of binge eating in adults; however, studies have not prospectively explored the effect of stimulants on LOC-E in youth. To explore this gap, the investigators aim to collect prospective observational data in a clinical setting to measure change in LOC-E episodes and secondary outcomes in youth aged 8 to 13 years old with ADHD and LOC-E who are treated with stimulants. The investigators will collect outcome measures prior to stimulant initiation (baseline) and 3 months after stimulant initiation.

null

Participation Requirements

  • Sex:

    ALL
  • Eligible Ages:

    8 to 13

Participation Criteria

Inclusion Criteria:

* Youth 8 to 13 years of age
* Able to provide informed consent
* Meet DSM-V diagnostic criteria for ADHD
* Experienced at least 3 episodes of LOC-E during the past 3 months, accompanied by some degree of distress and 2 of the 5 behavioural symptoms associated with LOC-E

Exclusion Criteria:

* Currently receiving treatment for overweight
* Taking medication with effects on eating behaviour
* Insufficient English language skills

Study Location

Abbie J Lane Memorial Building - QEII
Abbie J Lane Memorial Building - QEII
Halifax, Nova Scotia
Canada

Contact Study Team

Primary Contact

Aaron Keshen, MD

[email protected]
(902) 473-6288
Study Sponsored By
Nova Scotia Health Authority
Participants Required
More Information
Study ID: NCT05592119